HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated glycemia and local inflammation after injecting N-methyl-2-pyrrolidone (NMP) into the marginal ear vein of rabbits.

Abstract
The objective of this pilot study was to evaluate glycemia in rabbits by administering various vehicles for solubilizing poorly soluble candidate drugs used for the treatment of diabetes. Groups of three New Zealand White rabbits received intravenously: saline; 2.0 IU/kg insulin; 23 to 45% dimethyl acetamide (DMA)/10% cremophor (v:v) in water; or N-methyl-2-pyrrolidone (NMP). For the determination of glycemia, blood was collected just before and 0.25, 0.5, 1, 2, 4, and 24 h after injection. Glycemia after saline and DMA/cremophor injections remained stable and within the normal range (3.6 to 5.0 mmol/l). In insulin-injected rabbits, glycemia decreased (1 to 2 mmol/l) as expected. With NMP, glycemia was elevated (7.8 mmol/l), and animals were hyperactive upon injections. Injected ears gradually became bluish; 48 h after injection, they were edematous and necrotic. In conclusion, DMA/cremophor seems to be an acceptable vehicle. However, NMP may cause stress and local ear irritation when injected intravenously in rabbits.
AuthorsJ P Moreau, P J Vachon, M C Huneau
JournalContemporary topics in laboratory animal science (Contemp Top Lab Anim Sci) Vol. 40 Issue 1 Pg. 38-40 (Jan 2001) ISSN: 1060-0558 [Print] United States
PMID11300676 (Publication Type: Journal Article)
Chemical References
  • Hypoglycemic Agents
  • Pyrrolidinones
  • Teratogens
  • N-methylpyrrolidone
Topics
  • Animals
  • Diabetes Mellitus (drug therapy, veterinary)
  • Disease Models, Animal
  • Ear (innervation, pathology)
  • Hyperglycemia (chemically induced, veterinary)
  • Hypoglycemic Agents (administration & dosage, pharmacology)
  • Inflammation (chemically induced, veterinary)
  • Injections, Intravenous
  • Male
  • Necrosis
  • Pyrrolidinones (administration & dosage, adverse effects)
  • Rabbits
  • Solubility
  • Teratogens (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: